In a significant development for the respiratory health community, the American Thoracic Society (ATS) has received a generous donation of $50,000 from its Past President, Dr. William Martin, and his wife, Joyce Martin. This contribution is earmarked to bolster the strategic initiatives of the Public Advisory Roundtable (PAR), a coalition of over a dozen respiratory-related patient advocacy groups. The PAR’s mission is to ensure that the perspectives and lived experiences of patients remain at the forefront of ATS’s research, training, and policy advocacy efforts.
The ATS, an influential organization dedicated to improving lung health worldwide through research, clinical care, and public health initiatives, has long prioritized patient-centered approaches. The PAR was established 25 years ago under the visionary leadership of Dr. Martin, reflecting his enduring commitment to incorporating the patient voice into every aspect of respiratory science and medical practice. This newest donation reaffirms the importance of strategic patient engagement in accelerating advancements in respiratory medicine.
Dr. Martin’s tenure as the president of the ATS from 2000 to 2001 was marked by a dedication to fostering collaborative efforts between clinicians, researchers, and patient groups. His foresight in creating the PAR has transformed how the ATS integrates patient input, ensuring research agendas are aligned with real-world patient needs, thereby enhancing the relevance and efficacy of scientific discoveries and therapeutic innovations.
At the PAR annual meeting held in November 2025, Dr. Martin emphasized the need to ambitiously direct scientific and advocacy resources toward identifying curative therapies for individual respiratory diseases. This strategic pivot encourages a shift from managing symptoms to potentially eradicating conditions that significantly impair lung function, such as chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis, and severe asthma.
The recent donation from the Martins is set to expand and strengthen the PAR’s capacity to influence ATS activities. These include shaping research priorities and clinical guidelines that reflect patient experiences and align with unmet medical needs. By leveraging the expertise of PAR member organizations—comprising CEOs and top executives from various respiratory patient advocacy groups—the roundtable aims to amplify the voice of patients at the highest levels of policy and research decision-making.
Respiratory diseases remain among the leading causes of morbidity and mortality worldwide, making patient-centered research approaches imperative. These diseases often have complex etiologies and heterogeneous clinical presentations, which complicates diagnosis and treatment. Integrating patient-reported outcomes into clinical trials and routine care provides critical insights into disease impact and treatment effectiveness, thereby enhancing therapeutic development and health outcomes.
Dr. Raed Dweik, current ATS President, lauded the Martins’ generosity not only as a philanthropic milestone but as a beacon of hope that can inspire broader support for lung health initiatives on global scales. He underscored how patient advocacy, bolstered by strategic funding, catalyzes innovation in research and clinical practice, ultimately improving the quality of life for millions affected by respiratory disorders.
The investment in PAR underscores the growing trend in medical science toward participatory research, where patients act as collaborators rather than passive subjects. The adoption of precision medicine strategies in respiratory care increasingly relies on the heterogeneity captured in patient experiences, which guides biomarker discovery, phenotyping, and tailoring of therapies for maximal efficacy.
Furthermore, funding directed toward patient advocacy ensures that newly developed interventions are more equitably accessible, addressing disparities often observed in vulnerable populations disproportionately affected by respiratory illnesses. By fostering partnerships across scientific, clinical, and patient communities, the ATS-driven efforts exemplify model collaborations essential for translational success.
This generous gift stands as a testament to a long-standing vision held by Dr. Martin and his wife, recognizing that sustainable advances in respiratory medicine hinge on the meaningful inclusion of patients in all phases of research and healthcare delivery. Their leadership has set a foundation for a future where the ATS continues to bridge the gap between scientific discovery and patient well-being through integrated advocacy and strategic planning.
The PAR’s role extends beyond advocacy; it functions as a strategic advisory entity driving forward the ATS’s commitment to advancing respiratory health globally. Through initiatives enabled by donations like this, they will facilitate education, improve policy frameworks, and catalyze research partnerships that prioritize lung disease prevention, early diagnosis, and innovative treatments.
As the global burden of respiratory diseases continues to escalate—due to factors including aging populations, pollution, and emerging infectious threats like respiratory viruses—the imperative to engage patients fully in shaping research agendas and care paradigms grows ever more critical. The $50,000 donation to the ATS’s Public Advisory Roundtable is a vital step toward realizing this vision, fostering a healthcare ecosystem where patient insights drive scientific progress.
In summary, the philanthropic contribution by Dr. William Martin and Joyce Martin embodies a profound commitment to advancing the patient-centered mission of the American Thoracic Society. Their support will enhance the Public Advisory Roundtable’s strategic impact, driving ATS initiatives that integrate patient input within research and clinical frameworks to ultimately transform respiratory medicine and improve global lung health outcomes.
Subject of Research: Patient-centered advocacy and strategic planning in respiratory health research and policy.
News Publication Date: March 31, 2026
Web References:
- American Thoracic Society (https://site.thoracic.org/)
- Public Advisory Roundtable (PAR) (https://site.thoracic.org/advocacy-patients/par)
Image Credits: Dr. William Martin
Keywords: Philanthropy, Science advocacy, Health and medicine, Respiratory diseases, Patient-centered research, Lung health
